-
Jan 20, 2026, 6:48 pm90 ptsThe experimental mRNA-based drug sharply reduced the risk of recurrence or death when combined with immunotherapy Keytruda, according to the drugs’ sponsors.
Welcome to Politomix -- the political news wire where left, right and center mix.
Politomix aggregates the day's political news on the web and your mobile device.








